JP2012520325A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012520325A5 JP2012520325A5 JP2011554245A JP2011554245A JP2012520325A5 JP 2012520325 A5 JP2012520325 A5 JP 2012520325A5 JP 2011554245 A JP2011554245 A JP 2011554245A JP 2011554245 A JP2011554245 A JP 2011554245A JP 2012520325 A5 JP2012520325 A5 JP 2012520325A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- weight
- composition
- strain
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 26
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 19
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 18
- 229920001542 oligosaccharide Polymers 0.000 claims description 10
- 150000002482 oligosaccharides Chemical class 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 8
- 235000000346 sugar Nutrition 0.000 claims description 7
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 241000186012 Bifidobacterium breve Species 0.000 claims description 5
- 150000008163 sugars Chemical class 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 2
- 206010009944 Colon cancer Diseases 0.000 claims description 2
- 206010010774 Constipation Diseases 0.000 claims description 2
- 208000011231 Crohn disease Diseases 0.000 claims description 2
- 206010012735 Diarrhoea Diseases 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 206010009887 colitis Diseases 0.000 claims description 2
- 208000029742 colonic neoplasm Diseases 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 2
- 230000002757 inflammatory effect Effects 0.000 claims description 2
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 208000011580 syndromic disease Diseases 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 2
- 235000013406 prebiotics Nutrition 0.000 claims 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 8
- 239000013638 trimer Substances 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16008809P | 2009-03-13 | 2009-03-13 | |
| US61/160,088 | 2009-03-13 | ||
| PCT/US2010/027206 WO2010105207A1 (en) | 2009-03-13 | 2010-03-12 | Prebiotic oligosaccharides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012520325A JP2012520325A (ja) | 2012-09-06 |
| JP2012520325A5 true JP2012520325A5 (enExample) | 2013-04-25 |
Family
ID=42728831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011554245A Pending JP2012520325A (ja) | 2009-03-13 | 2010-03-12 | プレバイオティックオリゴ糖 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8425930B2 (enExample) |
| EP (1) | EP2405918B2 (enExample) |
| JP (1) | JP2012520325A (enExample) |
| AU (1) | AU2010223965A1 (enExample) |
| CA (1) | CA2760999A1 (enExample) |
| NZ (1) | NZ595174A (enExample) |
| WO (1) | WO2010105207A1 (enExample) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080126195A1 (en) | 2004-07-22 | 2008-05-29 | Ritter Andrew J | Methods and Compositions for Treating Lactose Intolerance |
| PL2032166T3 (pl) | 2006-06-13 | 2013-09-30 | Oncomed Pharm Inc | Kompozycje i sposoby diagnozowania i leczenia nowotworów |
| JP5618544B2 (ja) | 2007-01-24 | 2014-11-05 | オンコメッドファーマシューティカルズ インコーポレイテッド | 癌の診断および処置のための組成物および方法 |
| US9132189B2 (en) | 2008-07-08 | 2015-09-15 | Oncomed Pharmaceuticals, Inc. | Notch1 binding agents and methods of use thereof |
| CN102316897B (zh) | 2008-07-08 | 2014-11-05 | 昂考梅德药品有限公司 | Notch结合剂和拮抗剂及其应用方法 |
| WO2010098822A1 (en) | 2009-02-24 | 2010-09-02 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| EP3202406A1 (en) | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| SG10202110501RA (en) | 2010-12-31 | 2021-11-29 | Abbott Lab | Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides |
| WO2012092159A1 (en) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
| JP6129821B2 (ja) | 2011-05-13 | 2017-05-17 | グリコシン リミテッド ライアビリティー カンパニー | プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用 |
| BR112014001472A2 (pt) * | 2011-07-22 | 2017-02-21 | Abbott Lab | galactooligossacarídeos para prevenir lesões e / ou promover a cicatrização do trato gastrointestinal |
| US9463169B2 (en) | 2011-08-17 | 2016-10-11 | Microbiome Therapeutics, Llc | Human gastrointestinal microbiome modulating food supplement for improving blood glucose regulation |
| BR112014004772A2 (pt) | 2011-08-29 | 2017-03-21 | Abbott Lab | oligossacarídeos do leite humano para evitar danos e/ou promover a cura do trato gastrointestinal |
| US20150087616A1 (en) * | 2011-11-30 | 2015-03-26 | Ritter Pharmaceuticals, Inc. | Prebiotic formulations and methods of use |
| BR112015020977A2 (pt) | 2013-03-08 | 2017-07-18 | Axiom Foods Inc | suplemento de proteína de arroz e métodos de uso do mesmo |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| WO2014145276A1 (en) | 2013-03-15 | 2014-09-18 | Cargill, Incorporated | Carbohydrate compositions |
| GB201305708D0 (en) | 2013-03-28 | 2013-05-15 | Clasado Inc | Novel use |
| EP3542633A1 (en) * | 2014-03-06 | 2019-09-25 | Arla Foods amba | Lactose-reduced milk products containing galacto-oligosaccharides and limited amount of monosaccharides and a method of production |
| EP3164145A4 (en) | 2014-07-01 | 2018-01-17 | Probi Usa, Inc. | Bi-layer dual release probiotic tablets |
| US10752705B2 (en) | 2014-07-09 | 2020-08-25 | Cadena Bio, Inc. | Oligosaccharide compositions and methods for producing thereof |
| US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
| CN115350200A (zh) | 2014-12-08 | 2022-11-18 | 格礼卡姆股份公司 | 用于治疗代谢障碍的合成组合物 |
| US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
| US10881674B2 (en) | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| EP3229595B1 (en) | 2014-12-12 | 2021-02-03 | The Regents of the University of California | Reduction of milk glycans and their degradation products in the neonate gut |
| EP4205553A1 (en) | 2015-01-26 | 2023-07-05 | DSM Nutritional Products, LLC | Oligosaccharide compositions for use animal feed and methods of producing thereof |
| ES2857557T3 (es) | 2015-01-26 | 2021-09-29 | Kaleido Biosciences Inc | Compuestos terapéuticos de glicano y métodos relacionados de los mismos |
| SG11201708635QA (en) * | 2015-04-23 | 2017-11-29 | Kaleido Biosciences Inc | Microbiome regulators and related uses thereof |
| CA2983236A1 (en) | 2015-04-23 | 2016-10-27 | Kaleido Biosciences, Inc. | Glycan therapeutics and methods of treatment |
| EP3349763B1 (en) | 2015-09-14 | 2021-08-11 | Glycom A/S | Composition for use in microbiota modulation |
| WO2019119102A1 (en) * | 2017-12-22 | 2019-06-27 | Vitalus Nutrition Inc. | Method for producing galactooligosaccharides from lactose |
| US10337042B2 (en) | 2016-01-12 | 2019-07-02 | Vitalus Nutrition Inc. | Method for producing galactooligosaccharides from lactose |
| CA2992497C (en) * | 2016-01-12 | 2020-12-22 | Vitalus Nutrition Inc. | Method for producing galactooligosaccharides from lactose |
| EP3419630A4 (en) * | 2016-02-24 | 2019-11-06 | Glycom A/S | SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION |
| BR112018068261A2 (pt) | 2016-03-11 | 2019-01-15 | Evolve Biosystems Inc | microorganismo comensal transitório para melhorar a saúde do intestino |
| WO2017190755A1 (en) * | 2016-05-05 | 2017-11-09 | Glycom A/S | Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain |
| AU2017290900A1 (en) * | 2016-07-01 | 2019-01-17 | Infinant Health, Inc | Method for facilitating maturation of the mammalian immune system |
| US20180030403A1 (en) | 2016-07-28 | 2018-02-01 | Bobban Subhadra | Devices, systems and methods for the production of humanized gut commensal microbiota |
| WO2018048305A1 (en) | 2016-09-12 | 2018-03-15 | Rijksuniversiteit Groningen | Prebiotic branched galacto-oligosaccharides (gos) |
| CN109843073A (zh) * | 2016-09-19 | 2019-06-04 | 普罗莱克塔生物科学公司 | 经纯化的人乳低聚糖组合物 |
| WO2018065104A1 (en) * | 2016-10-07 | 2018-04-12 | Boehringer Ingelheim Vetmedica Gmbh | Analysis system and method for testing a sample |
| EP3634155A4 (en) | 2017-05-12 | 2021-02-17 | Axiom Foods Inc. | RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION |
| WO2019025637A1 (en) * | 2017-08-04 | 2019-02-07 | Nestec S.A. | PRECONDITIONED PROBIOTIC BACTERIA IN A GOS-CONTAINING ENVIRONMENT AND USE THEREOF |
| EP3703705B1 (en) | 2017-11-03 | 2024-05-15 | DSM Nutritional Products, LLC | Glucose-containing glycan preparations for use in the treatment of hyperammonaemia |
| KR102032799B1 (ko) | 2017-11-16 | 2019-10-17 | 고려대학교 산학협력단 | 해조류 유래 아가로트리오스의 제조방법 및 프리바이오틱로서의 용도 |
| JPWO2019117212A1 (ja) * | 2017-12-12 | 2020-12-03 | 森永乳業株式会社 | ビフィドバクテリウム属細菌を有効成分とする組成物 |
| US11304966B2 (en) | 2017-12-22 | 2022-04-19 | Glycom A/S | Composition comprising HMOs for preventing or reducing nociception |
| EP3801557A4 (en) | 2018-05-30 | 2022-03-09 | Evolve Biosystems Inc. | COMPOSITIONS AND METHOD OF USE FOR BIFIDOBACTERIUM LONGUM SUBSP. COMPETENT FOR H5 |
| EP3598901A1 (de) * | 2018-07-23 | 2020-01-29 | optiferm GmbH | Beta-galactosidase aus l. bulgaricus zur synthese von galactooligosacchariden in molke |
| KR20210058854A (ko) * | 2018-09-06 | 2021-05-24 | 프리슬랜드캄피나 네덜란드 비.브이. | 비피더스 활성 저알레르기성 gos 조성물 및 락토바실러스 델브루에키 ssp 불가리쿠스의 균주로부터의 베타-갈락토시다제를 수반하는 이의 제공 방법 |
| EP3646739A1 (en) | 2018-11-01 | 2020-05-06 | N.V. Nutricia | Nutritional composition comprising urea and non-digestible oligosaccharides |
| JP7502296B2 (ja) * | 2018-12-03 | 2024-06-18 | デュポン ニュートリション バイオサイエンシス エーピーエス | 高ｇｏｓ繊維レベル及び低ラクトースレベルを提供するためのラクターゼの使用 |
| CN109880813B (zh) * | 2019-03-20 | 2022-06-07 | 安徽大学 | 一种具有低聚半乳糖合成能力的β-葡萄糖苷酶及其表达菌株和应用 |
| EP3994163A1 (en) * | 2019-07-01 | 2022-05-11 | Société des Produits Nestlé S.A. | Serpin production |
| MX2022002949A (es) | 2019-09-24 | 2022-04-06 | Prolacta Bioscience Inc | Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes. |
| CN111849940B (zh) * | 2020-07-28 | 2022-03-25 | 量子高科(广东)生物有限公司 | 一种β-半乳糖苷酶的制备方法及其应用 |
| JP6978621B1 (ja) * | 2021-03-12 | 2021-12-08 | 森永乳業株式会社 | 組成物 |
| EP4101301A1 (de) * | 2021-06-08 | 2022-12-14 | DMK Deutsches Milchkontor GmbH | Verfahren zur herstellung von galactooligosacchariden |
| US12156859B2 (en) | 2021-12-20 | 2024-12-03 | Tainnovation Inc. | Methods of and compositions for treating obesity, obesity-related diseases or cancers using a N6-methyllysine/l-lysine mixture |
| WO2024112684A1 (en) * | 2022-11-22 | 2024-05-30 | Fairlife, Llc | Process for producing galactooligosaccharides |
| GB2628547A (en) | 2023-03-27 | 2024-10-02 | Univ Newcastle | Probiotic and postbiotic compositions, products and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3072670B2 (ja) * | 1992-02-28 | 2000-07-31 | 味の素株式会社 | ガラクトオリゴ糖の製造方法 |
| DE19701382A1 (de) * | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
| AU761477B2 (en) * | 1998-06-17 | 2003-06-05 | New Zealand Dairy Board | Bioactive whey protein hydrolysate |
| FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
| FR2844453B1 (fr) † | 2002-09-13 | 2006-05-19 | Agronomique Inst Nat Rech | Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii |
| MXPA05003597A (es) * | 2002-10-11 | 2005-06-03 | Wyeth Corp | Formulaciones nutricionales que contienen sustancias simbioticas. |
| GB0229015D0 (en) * | 2002-12-12 | 2003-01-15 | Novartis Nutrition Ag | New Compound |
| GB0308104D0 (en) * | 2003-04-08 | 2003-05-14 | Novartis Nutrition Ag | Organic compounds |
| EP1644482B2 (en) * | 2003-06-30 | 2014-10-01 | Clasado Inc. | Novel galactooligosaccharide composition and the preparation thereof |
| US20060115465A1 (en) * | 2004-10-29 | 2006-06-01 | Macfarlane George | Treatment of gastrointestinal disorders |
| US20070141678A1 (en) * | 2005-12-19 | 2007-06-21 | The Procter & Gamble Company | Processes for purifying oligosaccharides |
| EP1887017A1 (en) | 2006-08-09 | 2008-02-13 | Friesland Brands B.V. | Prebiotic carbohydrate |
| ATE524190T1 (de) † | 2006-10-02 | 2011-09-15 | Friesland Brands Bv | Hemmung von cholera-toxinen durch galatooligosacchariden (gos) |
| WO2008153377A1 (en) † | 2007-06-15 | 2008-12-18 | N.V. Nutricia | Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide |
-
2010
- 2010-03-12 CA CA2760999A patent/CA2760999A1/en not_active Abandoned
- 2010-03-12 US US12/722,813 patent/US8425930B2/en active Active
- 2010-03-12 NZ NZ595174A patent/NZ595174A/xx unknown
- 2010-03-12 AU AU2010223965A patent/AU2010223965A1/en not_active Abandoned
- 2010-03-12 WO PCT/US2010/027206 patent/WO2010105207A1/en not_active Ceased
- 2010-03-12 JP JP2011554245A patent/JP2012520325A/ja active Pending
- 2010-03-12 EP EP10751504.1A patent/EP2405918B2/en active Active
-
2013
- 2013-03-19 US US13/847,064 patent/US20140037785A1/en not_active Abandoned
-
2016
- 2016-07-22 US US15/216,974 patent/US20170000811A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012520325A5 (enExample) | ||
| RU2419445C2 (ru) | Уроновая кислота и пробиотики | |
| Chow | Probiotics and prebiotics: a brief overview | |
| AU2011333861C1 (en) | Oligosaccharide mixture and food product comprising this mixture, especially infant formula | |
| AU2011340881B2 (en) | Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases | |
| HRP20251128T1 (hr) | Smjesa hmo-a i bifidobakterija | |
| RU2012111253A (ru) | Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта | |
| RU2018107583A (ru) | Питательные композиции с 2fl и lnnt для применения при индукции кишечной микробиоты, которая похожа на кишечную микробиоту младенцев на грудном вскармливании | |
| TW201233334A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
| Ogueke et al. | Probiotics and prebiotics: Unfolding prospects for better human health | |
| CN101801220A (zh) | 含有非活的双歧杆菌和非消化性寡糖的营养物 | |
| MX2008011450A (es) | Mezcla simbiotica. | |
| US20120128634A1 (en) | Use of collinsella aerofaciens for reducing bloating | |
| CN102458152A (zh) | 具有β-1,3和β-1,4/1,6键的β-低聚半乳糖的协同混合物 | |
| Licht et al. | Prebiotics for prevention of gut infections | |
| CN101945658A (zh) | 用于预防婴儿肠道不适的包含婴儿双歧杆菌及低聚果糖和低聚半乳糖的组合物 | |
| RU2018127650A (ru) | Ферментированная молочная смесь с неперевариваемыми олигосахаридами | |
| Sharma et al. | Pre-and probiotics: Using functional foods in the fight against microbial resistance to antibiotics | |
| Sharma et al. | Prebiotics: A review of therapeutic potential | |
| TW201119661A (en) | Therapectic agent for influenza virus infection | |
| Crittenden et al. | Modifying the human intestinal microbiota with prebiotics | |
| Mohammadabadi | Probiotics and Prebiotics as Dietary Medicine | |
| Zhang et al. | Carbohydrates in Host Health Management and Their Application in Dairy Products | |
| CN103533851A (zh) | 益生元糖类组合物 | |
| Gil | Uncovering strategies to benefit from our gut microbiota: probiotics and prebiotics |